Company page

Castle Biosciences, Inc.

Castle Biosciences, Inc. is a public company traded under the ticker CSTL in the American market. The company has a market capitalization of approximately $732.77 million. Castle Biosciences focuses on developing and commercializing innovative diagnostic tests for patients with skin cancer and other diseases.